UP!

News

Aurinia Pharmaceuticals Inc. -0.27% (healthcare)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-07-06 Reiterated Rating Leerink Swann Outperform $7.00
2016-06-30 Initiated Coverage HC Wainwright Buy $7.00
2016-05-12 Reiterated Rating Canaccord Genuity Buy
2016-02-17 Reiterated Rating Canaccord Genuity Buy $10.00
2016-02-09 Reiterated Rating FBR & Co. Buy $9.00
2016-02-09 Reiterated Rating FBR & Co Buy $9.00
2016-02-08 Reiterated Rating Canaccord Genuity Buy $10.00
2016-01-20 Reiterated Rating FBR & Co. Outperform
2015-11-16 Reiterated Rating Canaccord Genuity Buy $10.00
2015-10-30 Reiterated Rating FBR & Co. Outperform
2015-08-13 Reiterated Rating Canaccord Genuity Buy $10.00
2015-05-08 Initiated Coverage MLV & Co. Buy $9.00
2015-02-09 Reiterated Rating Canaccord Genuity Buy $10.00
2015-02-02 Initiated Coverage Leerink Swann Outperform $8.00
2014-10-27 Initiated Coverage Canaccord Genuity Buy $10.00
2016-07-06 Reiterated Rating Leerink Swann Outperform $7.00
2016-06-30 Initiated Coverage HC Wainwright Buy $7.00
2016-05-12 Reiterated Rating Canaccord Genuity Buy
2016-02-17 Reiterated Rating Canaccord Genuity Buy $10.00
2016-02-09 Reiterated Rating FBR & Co. Buy $9.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks

Comments